Multivariate analysis of prognostic factors
correlated with response to Zevalin for NHL
• Analysis of 4 clinical registrational studies
• Patients with extensive prior therapy (1-9 regimens), bulky disease,
splenomegaly
• Disease bulk (< 5 cm) correlated with overall response rate (89
patients ORR 90% (p<0.001)
• Other unfavourable characteristics (high LDH, extranodal disease,
splenomegaly, extensive prior therapy, elevated peripheral B cell
count) that might have been expected to confer a reduced probability
of response failed to do so
Czuczman et al Proc ASCO 2002